Audible has launched a free loyalty programme that gives paying members discounts, credits and anniversary gifts for listening to audiobooks, marking a broader push by Amazon’s audio unit to make subscription use feel more rewarding beyond monthly credits and catalogue access. The programme, called Audible Rewards, is being rolled out first in the United States for members on Standard and Premium plans. It allows users to earn [...]
Cyber espionage operators are using a newly documented Windows backdoor called HazyBeacon to target government networks in Southeast Asia, turning legitimate Amazon Web Services infrastructure into a covert command-and-control channel that can blend into ordinary cloud traffic. The activity, tracked as CL-STA-1020, has been linked to intelligence-gathering operations focused on sensitive state information, including material tied to tariffs, trade disputes and government policy discussions. Security researchers have [...]
Advancing Cross-Border Payments Across Latin America and Europe
AMSTERDAM, NETHERLANDS – Media OutReach Newswire – 3 June 2026 – XTransfer, the world’s leading B2B cross-border trade payment platform, and BBVA, a global financial group, have signed a Memorandum of Understanding (MOU) during Money20/20 Europe 2026 in Amsterdam to deepen cross-border payment infrastructure across Latin America and Europe.
The MOU was signed by Bill Deng, Founder and CEO of XTransfer, and Ksenia Nekrasova, Global Sector Co-Head of TMT at BBVA, at Money20/20 Europe 2026 in Amsterdam.
Under the MOU, XTransfer and BBVA will combine their respective strengths to explore the delivery of integrated cross-border financial solutions, spanning FX conversion, local payments and cross-border payments across Latin America, Europe and Hong Kong SAR.
The parties will also explore leveraging technology and innovation, including APIs, digital platforms, collection solutions and virtual accounts, to support more automated, real-time and seamless FX conversion and transaction processing. By streamlining payment flows and improving operational connectivity, the collaboration is expected to enhance the scalability, efficiency and reliability of cross-border financial services for SMEs engaged in international trade.
In recent years, trade between China and Latin America has grown closer. XTransfer data shows that in 2025, payment collections from Latin America on its platform rose 94% y-o-y. Yet many SMEs still face major cross-border settlement hurdles, including slow onboarding, FX constraints, and complex compliance. The partnership between XTransfer and BBVA is structured to tackle these barriers directly.
For XTransfer, the partnership strengthens the coverage and depth of X-Net, its global unified B2B cross-border settlement and risk management network, in two of the most important regions for its SME clients. With Latin America emerging as a high-growth corridor for Chinese exporter settlements, BBVA’s strong presence across Latin America and Europe further strengthens XTransfer’s reach and competitive position.
With XTransfer’s network of more than 897,000 SME clients worldwide, the partnership also strengthens BBVA’s position in global payments and expands its ability to serve a broader, more diverse client base across multiple regions.
Bill Deng, Founder and CEO of XTransfer, said, “Latin America remains an active but underserved B2B trade corridor, where SMEs still encounter significant challenges. We are pleased to sign this MOU with BBVA, enabling us to leverage their expertise to bring X-Net’s infrastructure directly into the region. Together, we aim to simplify cross-border finance and improve the efficiency and inclusivity for global traders.”
Ksenia Nekrasova, Global Sector Co-Head of TMT at BBVA, said: “Beyond the growth in flows, we are seeing a shift in how our clients operate: digital platforms with global, real-time and highly integrated needs. This agreement allows us to anticipate that evolution, strengthening our capabilities in the TMT space and supporting these clients in their international expansion with solutions designed for their scale and complexity.” Hashtag: #XTransfer #BBVA #CrossborderPayments #SMEs
The issuer is solely responsible for the content of this announcement.
About XTransfer
XTransfer, the world’s largest B2B cross-border trade payment platform with over US$60 billion TPV in 2025, according to CIC. Founded in 2017 as one of the first payment platforms worldwide dedicated to B2B cross-border trade, we serve the largest customer base of over 800,000 registered SMEs globally as of March 31, 2026.
We connect top-tier financial institutions directly to SMEs, the backbone of global trade, giving businesses of every size access to the same secure, compliant and seamless payment infrastructure once reserved for multinationals. As of March 31, 2026, we provide payment services across more than 200 countries and regions through partnerships with financial institutions, including some of the most established international banks around the world.
XTransfer has obtained required licenses in major hubs, including the Chinese Mainland, Hong Kong, the United Kingdom, the United States, Singapore, the Netherlands, Australia and Canada.
For more information, please visit: https://www.xtransfer.com
Kioxia Holdings has moved within striking distance of Toyota Motor’s market value, underscoring how the artificial intelligence boom is reshaping Japan’s corporate hierarchy and lifting a memory-chip maker that listed in Tokyo less than two years ago into the country’s market elite.
The Tokyo-based maker of NAND flash memory and solid-state drives has become one of the most closely watched stocks on the Tokyo Stock Exchange after a sharp rally tied to demand for data-centre storage, AI servers and high-performance memory systems. Its market capitalisation has climbed into the tens of trillions of yen, placing it near Toyota and behind SoftBank Group in a reshuffled ranking that would have seemed unlikely when Kioxia priced its initial public offering at 1,455 yen a share in December 2024.
The shift marks a wider challenge to the long-standing dominance of Japan’s manufacturing champions. Toyota, the global carmaker that symbolised the strength of Japan Inc. for decades, has been displaced from the top position by SoftBank during the latest AI-led surge, while Kioxia has risen rapidly from a former Toshiba memory unit backed by Bain Capital into a central player in the market’s technology rotation.
Kioxia’s climb reflects investor expectations that memory will remain a bottleneck in AI infrastructure. Generative AI systems require vast amounts of storage and high-speed data movement, pushing demand beyond the older cycle driven mainly by smartphones and personal computers. Data-centre operators, cloud companies and chip designers are competing for components needed to train and run large AI models, giving memory producers stronger pricing power after years of volatility.
The company’s earnings have strengthened sharply. Kioxia has projected operating profit of about 1.3 trillion yen for the April-June quarter, a figure that puts it among the most profitable listed companies in Japan. Its latest annual results showed strong momentum in revenue, margins and cash generation, helping ease earlier concerns about debt and cyclicality. Rating upgrades to investment grade have added to the perception that the balance sheet is improving at a time when investors are rewarding semiconductor exposure.
Kioxia’s origins give its rise broader industrial significance. The company traces its roots to Toshiba’s memory business, which was sold to a Bain-led consortium in 2018 after Toshiba’s financial crisis. The group was renamed Kioxia in 2019, drawing on the Japanese word for memory and the Greek word for value. Its public listing in 2024 valued it below 800 billion yen, after earlier IPO attempts were delayed by weak valuation conditions and pressure in the memory market.
That cautious debut contrasts sharply with its current status. Shares have multiplied as investors reassessed the role of NAND flash in AI systems, especially as large-scale data centres require higher storage density, faster access and more energy-efficient hardware. Kioxia has also been developing advanced BiCS FLASH technology and promoting next-generation SSDs for AI storage infrastructure.
The rally has also lifted questions over valuation risk. Memory chips remain one of the semiconductor industry’s most cyclical segments, with prices exposed to shifts in capital spending, inventory levels and customer demand. A sharp rise in market value leaves Kioxia vulnerable if hyperscaler investment slows, if competitors add capacity faster than expected, or if customers push back against higher pricing.
Competition is intense. Samsung Electronics, SK Hynix, Micron Technology and SanDisk remain key players across memory markets, with SK Hynix holding a dominant position in high-bandwidth memory used in AI accelerators. Kioxia’s strength is more closely tied to NAND flash and SSDs, where demand from AI infrastructure has broadened the market but does not eliminate the risk of oversupply once new capacity comes on stream.
Toyota’s relative decline in the rankings does not point to operational weakness alone. The carmaker remains one of the world’s largest manufacturers by sales and a major profit generator, but investors have been rotating away from traditional industrial leaders towards companies with direct AI exposure. Concerns over electric-vehicle competition, currency movements and the cost of future technologies have weighed on auto valuations, even as Toyota continues to command global scale in hybrid vehicles and supply-chain management.
SoftBank’s ascent has further highlighted the changing market narrative. Its exposure to Arm and AI-related investments has drawn investors seeking Japan-based access to global AI infrastructure. Together, SoftBank and Kioxia now represent a market story centred on chips, data centres, software platforms and computing capacity rather than the export-led industrial model that long defined Japan’s equity market.
Foreign investor flows have amplified the shift. Japan’s equity market has benefited from corporate-governance reforms, stronger capital returns and renewed interest in companies linked to the AI supply chain. The Nikkei 225 has reached record territory, though the rally has been uneven, with gains concentrated in a limited group of technology-linked names while broader market performance has been more mixed.
Kioxia’s next test will be whether it can convert favourable pricing and sold-out capacity into durable earnings. Investors will look for clearer shareholder-return plans, disciplined capital expenditure and evidence that AI storage demand can remain strong beyond the current investment wave. The company’s contemplated US share listing would widen access to global technology investors and could further raise its profile if market conditions remain supportive.
Arabian Post Staff -Dubai Al Ansari Exchange recorded a sharp rise in companies using its Wage Protection System platform on June 1, as private-sector employers across the UAE moved to meet tighter salary-payment rules that took effect at the start of the month. The UAE remittance and foreign exchange company said the number of companies processing salaries through its WPS platform rose by more than 151 per […]
Zoom has launched ZoomMate, an agentic AI work surface designed to convert meeting conversations into completed tasks, documents and workflows, marking a deeper push by the video communications company into enterprise automation. The product, announced on June 1, is aimed at reducing the gap between workplace discussion and follow-through. It combines enterprise search, AI-generated content, workflow orchestration and automated execution across applications such as Salesforce, Jira, Slack, [...]
Arabian Post Staff -DubaiAbu Dhabi’s AD Ports Group has agreed to acquire Corredor Logística e Infraestrutura, a São Paulo-based agribulk terminal operator, in an AED3.1 billion deal that gives the company its first operating platform in Latin America and a stronger position in global food supply chains. The transaction, valued at about $835 million, is the largest acquisition undertaken by AD Ports Group and is expected to […]
Between 2018 and 2023, Dr Ivan Puah treated over 550 cases, addressing unique challenges in Singapore’s multi-ethnic population. His study included diverse case profiles. Results revealing no complications and high satisfaction prove the need to adapt surgical techniques for variations in skin type between Asian and Caucasian patients.
SINGAPORE – Media OutReach Newswire – 3 June 2026 – The evaluation and management of surgical treatment for gynecomastia primarily focus on Western populations. However, Amaris B. Clinic’s decades of experience in Singapore highlight specific considerations for Asian patients.
Dr Ivan Puah, Medical Director at Amaris B. Clinic and the lead researcher on a recent study, has offered new insights into treating gynecomastia, a condition characterised by male breast enlargement, in Singapore.
The research paper titled ‘Surgical Management of Gynecomastia in Asian Men – Clinical Experience and Considerations for Different Patient Types’ provides detailed, important considerations, including the management of the consultation process, addressing varying patient expectations, and tackling the surgical aspects necessary to achieve desired aesthetic outcomes.
Between 2018 and 2023, Dr Puah treated over 550 cases at Amaris B. Clinic and presented six representative patient cases that illustrate the demographics and unique challenges faced by this multi-ethnic Asian population.
The typical patient profiles included obese, overweight, and lean adults, as well as adolescents. Common causes of gynecomastia observed in the patients included hormonal changes during puberty, drug-induced gynecomastia from anabolic steroids, and conditions related to weight loss.
Dr Puah’s proprietary surgical methods involve making a single incision along the areola to minimise scar visibility while effectively excising glandular tissue, performing liposuction to remove excess fat, and tightening the chest skin.
Six case studies of diverse gynecomastia patient profiles
Gynecomastia Grade
Demographic
Profile
Grade II
17-year-old Chinese
A history of bilateral breast enlargement since 13 years-old
Grade II
18-year-old Chinese
A history of bilateral breast enlargement since 12 years-old
Grade II
22-year-old Malay
Using anabolic hormone supplements for bodybuilding for 4 years
Grade II
46-year-old Chinese
Took anabolic steroids for 5 years
Grade IV
28-year-old Chinese
Overweight since childhood
No reduction in breast enlargement despite losing weight
Skin laxity present
Grade IV
21-year-old Indian
Overweight since childhood
No reduction in breast enlargement despite losing weight
Skin laxity present
At the 3-month follow-up after surgery, 5 of 6 patients reported no complications, highlighting the effectiveness of the tailored surgical approach. They expressed high satisfaction with the aesthetic results of the procedure, rating it a perfect 7 out of 7, and reported relief from emotional distress.
Only one patient experienced mild keloid formation at the edges of both areolae where incisions were made, which were not easily noticeable, and reported no complications or dissatisfaction.
Dr Ivan Puah emphasises, “It is important to adapt surgical techniques to address issues such as scarring and hyperpigmentation, which can be more pronounced in Asian patients due to their skin types. The differences in skin quality and glandular tissue characteristics between Asian and Caucasian patients with gynecomastia necessitate distinctions in treatment planning, particularly regarding careful incision placement.”
The issuer is solely responsible for the content of this announcement.
ABOUT AMARIS B. CLINIC
Amaris B. Clinic, established in 2004 in Singapore and led by Dr Ivan Puah, focusing on medical aesthetics and cosmetic surgery.
The clinic offers facial and body sculpting services such as liposuction, gynecomastia surgery, and fat grafting, as well as non-surgical treatments like Ultherapy Prime, biostimulator injections, and hair loss therapy.
Dr Puah, an MOH-accredited liposuction doctor with extensive training in various cosmetic procedures, is committed to providing personalised care with an artful eye and proven medical techniques.
Dedicated surgical training in gynecomastia surgery in San Francisco
Chairman of the Lipo Peer Review Committee in Singapore
Trained in Vaser liposuction (fundamental and hi-definition) in Colorado and Argentina
Trained in syringe liposculpture, fat grafting, and thread lift from renowned French plastic surgeon, Dr Pierre Francois Fournier
Appointed trainer by Allergan and Merz for fellow doctors on cosmetic injectables
Designated trainer for PDO thread lift and Picolaser from Venusys Medical
Graduate Diploma in Family Dermatology from NUS
Graduate Diploma in Acupuncture from TCMB
Graduate Diploma in Sports Medicine from LKCMedicine, NTU
Jean-Jacques Muyembe and Peter Piot are being honored with the international award of €500,000 for exceptional life-long leadership spanning five decades since the first outbreak of Ebola
BERLIN, GERMANY – Newsaktuell – 2 June 2026 – The Virchow Prize 2026 has been jointly awarded to Jean‑Jacques Muyembe and Peter Piot for their pioneering and enduring leadership in the discovery, control, and understanding of epidemic threats, and for advancing equitable, multilateral cooperation and governance that have fundamentally strengthened global preparedness and solidarity in the face of infectious disease outbreaks.
The Virchow Prize Laureates 2026: Jean-Jacques Muyembe (DR Congo) and Peter Piot (Belgium), honored for their pioneering and enduring leadership in the discovery, control, and understanding of epidemic threats, and for advancing equitable, multilateral cooperation and governance that have fundamentally strengthened global preparedness and solidarity in the face of infectious disease outbreaks.
The announcement was made today by the Virchow Foundation which is granting the annual award. The selection of the laureates by the independent Virchow Prize Committee was preceded by a nomination period that ended on February 28, followed by a three-month deliberation period.
This moment resonates with particular historical gravity: 2026 marks both fifty years since the emergence of Ebola and a renewed confrontation with the virus through the current outbreak and unpreparedness.
According to the committee, the careers of Jean‑Jacques Muyembe and Peter Piot are anchored in a defining moment of modern infectious disease history: the first identified Ebola outbreak in 1976. Their collaboration demonstrated the necessity of crossing contextual, disciplinary and geographic boundaries, highlighting both the potential and the inequities inherent in global health partnerships. Over the decades, both Muyembe and Piot have worked – partly closely together, partly independent from each other in complementary ways – to transform epidemic research in an exemplary manner, firmly rooted in equity, reciprocity, and shared leadership.
Taken together, the laureates’ contributions illustrate a continuum that is central to advancing health for all: from discovery to delivery, from local response to global coordination, from emergency action to long-term system strengthening. Their work has directly improved the ability to detect, understand, and control deadly outbreaks, while also influencing broader frameworks for addressing global health challenges in a manner that is equitable and inclusive.
By awarding the Virchow Prize 2026 equally to Muyembe and Piot, their scientific achievements and their commitment to strengthening health systems and fostering global solidarity are honored. The laureates’ work embodies Rudolf Virchow’s legacy that health is inseparable from social organisation, governance, and collective responsibility.
Greenlogue/AP Green GSM Philippines has secured a strategic financing and digital banking partnership with Philippine National Bank, giving the all-electric ride-hailing operator fresh support for fleet expansion, driver payroll and nationwide growth as the Philippines accelerates its shift towards cleaner urban transport. The partnership centres on P2 billion in credit facilities extended by PNB to finance the acquisition of electric vehicles and support working capital requirements. The […]
MANILA, PHILIPPONES – Media OutReach Newswire – 1 June 2026 –Green GSM Philippines and Philippine National Bank (PNB) officially announced a strategic partnership in financial and digital banking services to support the operations and expansion of Green GSM’s all-electric ride-hailing ecosystem in the Philippines. The agreement marks the next step in Green GSM’s strategy to develop the infrastructure supporting its electric mobility model, as the company continues to expand across major urban areas and gradually build a sustainable long-term operating ecosystem in the Philippine market.
Mr. Edwin R. Bautista, President and Chief Executive Officer of Philippine National Bank (third from left); Ms. Thuy Vu Dropsey, Chief Corporate Development & Strategic Finance Officer at Vingroup (third from right); and Mr. Dao Quy Phi, Managing Director of Green SM Southeast Asia (far right), together with representatives of the parties at the partnership signing ceremony between Green GSM and Philippine National Bank. Under the partnership, PNB provided a PHP 2 billion credit facility to support Green GSM’s operational expansion and fleet growth in the Philippines. The facility supported Green GSM’s fleet expansion and operating capacity in the Philippines.
Alongside the credit facility, the two parties also implemented digital account management and payment systems for Green GSM’s driver network. Through PNB’s corporate banking platform and digitized onboarding processes, account opening and activation times are significantly reduced, helping Green GSM strengthen operational management as it expands driver network.
As cities continue to seek lower-emission transport solutions, financial systems, digital payments, driver management and operating standards are becoming increasingly important to supporting mobility platforms at scale.
In the Philippines, Green GSM is building mobility model through the integration of technology, an all-electric fleet, and standardized operating systems. Following its strategic partnership with Xentro Group in 2025 and the launch of the Green Xentro fleet in Rizal earlier this year, the company continues to expand its presence through long-term collaborations with local partners and domestic financial institutions.
“We appreciate Green GSM’s long-term development direction in the Philippines, not only in advancing low-emission mobility, but also in the way the company is building an operating model with scalability and clear governance foundations,” said Mr. Edwin R. Bautista, President and Chief Executive Officer of PNB. “The transition toward sustainable transport will require ecosystems capable of supporting stable long-term growth, together with the financial and operational foundations needed to enable that expansion.”
Ms. Le Thi Thu Trang, Chief Executive Officer of Green GSM Philippines, said: “For Green GSM, developing an all-electric mobility model is not only about expanding the fleet, but also about building an operating system that is stable, standardized, and capable of sustainable long-term growth. Our partnership with PNB will help strengthen the financial and operational foundations needed to enhance service quality and support Green GSM’s continued expansion in the Philippines.”
Green GSM develops its all-electric mobility model through the combination of technology, standardized operating systems, and professionally trained drivers. The platform is supported by real-time monitoring and operational systems designed to maintain service consistency across major urban areas.
The partnership with PNB further reinforces Green GSM’s long-term direction in the Philippines, where the company continues to strengthen its operating foundations, service standards, and driver support systems in order to maintain service quality as operations scale further.
Hashtag: #GreenSM
The issuer is solely responsible for the content of this announcement.
About GSM & Green SM
GSM (Green Smart Mobility) is a pioneering multi-platform company operating all-electric ride-hailing services. With a focus on sustainable transport development, GSM operates a mobility model powered entirely by VinFast electric vehicles, combining technology, service standards, and operational ecosystems to support the future of low-emission urban mobility.
Green GSM is GSM’s official brand in the Philippines and is part of the broader Green SM global ecosystem, alongside Xanh SM in Vietnam and Laos, and Green SM in Indonesia. Across all markets, the brand focuses on delivering modern mobility experiences through VinFast electric vehicles, professional drivers, and operating systems built around safety, consistency, and service quality.
About Philippine National Bank (PNB)
Philippine National Bank (PNB) is one of the Philippines’ largest private commercial banks in terms of assets and deposits. The bank provides a full range of financial and banking services to individual customers, businesses, institutions, and overseas Filipino communities. With a history spanning more than a century, PNB continues to focus on growth strategies driven by digital transformation, operational efficiency, and sustainable development in the financial sector.
Arabian Post Staff -Dubai UAE regulators have approved the oral form of Wegovy for weight management and cardiovascular risk reduction, expanding access to one of the world’s most closely watched obesity treatments beyond weekly injections. Emirates Drug Establishment cleared Wegovy, the semaglutide medicine developed by Novo Nordisk, as a once-daily tablet for adults living with obesity or overweight linked to weight-related health conditions. The approval makes the […]
Amazon Web Services has begun replacing parts of its data centre networking system with a flatter, quasi-random architecture aimed at moving cloud traffic faster while reducing the amount of equipment, electricity and physical cabling needed inside its facilities. The shift marks a notable change in the way one of the world’s largest cloud operators builds the internal networks that connect servers, storage systems and routers across its [...]
A sweeping overhaul of the UAE’s civil law takes effect on June 1, lowering the age of legal adulthood to 18 and reshaping how residents, families, companies and young people handle contracts, assets, liabilities and disputes. Federal Decree-Law No. 25 of 2025 on the Civil Transactions Law replaces Federal Law No. 5 of 1985, the country’s four-decade-old Civil Code. The new framework is one of the most [...]
Arabian Post Staff -Dubai A sweeping overhaul of the UAE’s civil law takes effect on June 1, lowering the age of legal adulthood to 18 and changing how contracts, compensation claims, civil disputes and legal obligations are interpreted across the country. Federal Decree-Law No 25 of 2025 on the Civil Transactions Law replaces the 1985 framework that has underpinned much of the UAE’s private law system for […]
Low levels of vitamin B12 and folate may be tied to persistent fatigue and weaker motivation even among adults who appear otherwise healthy, adding a nutritional dimension to a complaint often blamed on poor sleep, stress or heavy workloads. A research team in Japan examined blood markers and self-reported symptoms in about 600 healthy adults and found that higher levels of homocysteine, a compound that tends to [...]
OpenRouter has raised $113 million in Series B funding, marking one of the strongest investor endorsements yet for the fast-growing layer of artificial intelligence infrastructure that helps developers and companies route work across competing AI models rather than rely on a single provider. CapitalG, Alphabet’s independent growth fund, led the round, with participation from NVentures, the venture capital arm of NVIDIA, as well as ServiceNow Ventures, MongoDB [...]
Shrey Parikh, a 14-year-old speller from California, won the 2026 Scripps National Spelling Bee after a high-speed tiebreaker that capped one of the competition’s most dramatic finals, correctly spelling 32 words in 90 seconds to defeat 12-year-old Ishaan Gupta of Jersey City, New Jersey. The eighth-grader from Rancho Cucamonga secured the title at DAR Constitution Hall in Washington after the two finalists reached a spell-off following a [...]
Arabian Post Staff -Dubai Emirates NBD has extended its push to draw more retail investors into UAE equity markets by offering zero commissions on local share trading through ENBD X, its digital wealth platform, sharpening competition among banks and brokerages seeking a bigger role in the country’s expanding investment ecosystem. The initiative allows eligible customers to buy and sell shares listed on Dubai Financial Market, Abu Dhabi […]
Group sales US$3,650 million – up 0.1% compared to the prior year; a decrease of 2% on a constant currency basis
Gross profit US$840 million or 23.0% of sales (compared to US$843 million or 23.1% of sales in the prior year)
Adjusted EBITA US$287 million or 7.9% of sales (compared to US$344 million or 9.4% of sales in the prior year)
Net profit attributable to shareholders totalled US$202 million – a decrease of 23% compared to the prior year
Net profit, excluding non-cash unrealized currency movements, restructuring costs, impairment of certain intangible assets, and adverse fair value movements in investments, declined by 13% to US$234 million
Free cash flow from operations totalled US$217 million compared to US$286 million in the prior year
A recommended final dividend of 44 HK cents per share (5.64 US cents)
As of 31 March 2026, cash reserves amounted to US$902 million (compared to US$791 million at the prior year end); and the ratio of total debt to capital was 10%
HONG KONG SAR – Media OutReach Newswire – 28 May 2026 – Johnson Electric Holdings Limited (“Johnson Electric”), a global leader in electric motors and motion subsystems, today announced its results for the twelve months ended 31 March 2026.
Group sales for the 2025/26 financial year were US$3,650 million, an increase of 0.1% compared to the prior year. Net profit attributable to shareholders decreased by 23% to US$202 million or 21.59 US cents per share on a fully diluted basis. Adjusted net profit, excluding the effects of non-cash foreign exchange rate movements, the impairment of intangible assets, restructuring charges, and adverse fair value movements in investments, declined by 13% to US$234 million.
Sales Performance
The Automotive Products Group (“APG”) achieved sales of US$3,054 million, which amounted to 84% of total Group sales. Excluding currency effects, APG’s sales decreased by 3%.
Global automotive industry production volumes increased slightly over the prior year, but growth remains lacklustre in most markets due to affordability concerns and the challenges faced by OEMs and suppliers in adjusting to geopolitical uncertainty, tariff pressures, and the shifting economics of battery electric vehicles that continue to be shaped by the level of government subsidies available to consumers.
APG’s sales are divided broadly equally across the three major geographic regions of demand, but performance over the past year reflected distinct variations in local market conditions, as well as APG’s own mix of OEM customers and the timing of new program launches.
In Asia, the division’s sales declined by 7% on a constant currency basis primarily due to the ongoing erosion in market share held by Sino-foreign joint venture OEM customers in China. APG has continued to win significant new business awards from Chinese domestic OEMs and their suppliers, which now account for the majority of its sales in China. However, the division’s historically large share among joint venture customers has acted as a drag on its recent sales performance that is taking time to reverse. The domestic passenger vehicle market in China itself experienced a sharp slowdown in sales in the first quarter of 2026 due to the phasing out of trade-in subsidies designed to encourage the purchase of electric vehicles.
APG’s sales to the Americas increased by 1% on a constant currency basis in a market that saw total light vehicle production volumes broadly flat. The predominant factor constraining new car sales in North America is cost of living concerns, with many low to middle income car buyers struggling to afford new vehicles that, on average, have increased in price by over 30% since 2020.
In Europe, APG’s sales decreased by 2% on a constant currency basis. The European auto market continues to experience sluggish consumer demand at the same time that OEMs are hampered by excess production capacity and the impact of shifting emissions regulations on their product model line-ups.
APG’s strategy in the context of the varied and unpredictable operating environment for component suppliers is, firstly, to focus on bringing to market innovative motion technologies that enable electrification, reduce emissions, and enhance passenger safety and comfort. Secondly, APG aims to offer its diverse base of customers an unrivalled total cost and value proposition that combines speed, scale, and reliability of production with an adaptable global operating footprint.
The Industry Products Group (“IPG”) achieved sales of US$596 million – an increase of 2% compared to the prior year on a constant currency basis. After three successive years of declining sales, this marks an important return to growth for the division. In more commoditized product application segments, new business development has been redirected towards the rapidly growing base of Chinese manufacturers who are capturing an increasing share of the global market for consumer and commercial hardware goods – particularly for low-priced, entry-level products. In parallel, IPG is focused on supplying motion subsystem solutions to more specialized, higher-growth segments, including humanoid robotics, warehouse automation, medical devices, semiconductor manufacturing equipment, and liquid cooling applications.
Gross Margins and Operating Profitability
The Group’s gross profit of US$840 million, or 23.0% of sales, was essentially flat compared to the prior financial year. Slight increases in production staff costs, depreciation, and raw materials were offset by savings in other production overheads and direct labour.
Reported earnings before interest, tax and amortization (“EBITA”) amounted to US$258 million, a decrease of 22% compared to US$331 million achieved in the prior year. The decline was due to a combination of factors, including higher selling and administrative staff costs and other provisions, an impairment of intangible assets arising from a past acquisition, and reduced other income due to an adverse net change in the fair value of certain investments.
Net Profit and Financial Condition
Net profit attributable to shareholders decreased by 23% to US$202 million or 21.59 US cents per share on a fully diluted basis. Adjusted net profit, excluding the effects of non-cash foreign exchange rate movements, the impairment of intangible assets, restructuring charges, and adverse fair value movements in investments, amounted to US$234 million compared to US$268 million in the prior year.
The Group’s overall financial condition remains robust with a total debt to capital ratio of 10%, an interest coverage ratio of 22 times, and year-end cash reserves of US$902 million.
Dividends
The Board considers it appropriate to recommend maintaining the final dividend of 44 HK cents (5.64 US cents) per share, which together with the interim dividend of 17 HK cents per share, represents a total dividend of 61 HK cents (7.82 US cents) per share.
Chairman’s Comments on the Annual Results and Outlook
Commenting on the annual results for the financial year 2025/26, Dr. Patrick Wang, Chairman and Chief Executive, said, “Operating conditions for global manufacturing businesses during the financial year 2025/26 remained challenging, with end-market demand in most regions subdued and geopolitical events and uncertainties placing upward pressure on input costs.”
Dr. Patrick Wang further commented: “In the face of these headwinds, Johnson Electric maintained its long-standing resilience with sales and gross profit margins both holding up comparatively well. The bottom-line result, however, was negatively impacted by the effects of higher overhead expenses on a flat sales base, adverse net changes in the fair value of investments, and a non-cash intangible assets impairment charge.”
Concerning the near-term financial outlook, Dr. Patrick Wang said: “The global economy demonstrated resilience over the past year, despite the protracted conflict between Russia and Ukraine and the geopolitical shock of tariffs being imposed on US imports of goods from almost all countries. Looking ahead, the unstable and unpredictable conditions for trade and global manufacturing have been made even more precarious by the outbreak of war in the Middle East.”
“Johnson Electric has a long-standing track record in successfully navigating volatile global markets. In the near term, with geopolitical and macro-economic dynamics impossible to forecast with precision, management remains focused on cost control, managing the effects of inflation, and maintaining a prudent financial risk profile.”
“In parallel, however, we are also committed to invest in adapting and scaling our business model to meet strong underlying demand for our motion subsystem solutions in several high-growth end-markets and new product applications. Included among these are: thermal management systems for electric and hybrid vehicles that depend on a combination of water pumps, valves and actuators to support optimal vehicle cabin temperature, extend electric vehicle driving range, and contribute to longer battery life; solid oxide fuel cell power generation systems that are becoming established as an important source of low-emission, on-site electricity supply to AI data centres; and AI-enabled humanoid robots, which are widely viewed as one of the most significant industrial and commercial opportunities over the next ten to twenty years.”
Forward Looking Statements
This news release contains certain forward looking statements with respect to the financial condition, results of operations and business of Johnson Electric and certain plans and objectives of the management of Johnson Electric.
Words such as “outlook”, “expects”, “anticipates”, “intends”, “plans”, “believe”, “estimates”, “projects”, variations of such words and similar expressions are intended to identify such forward looking statements. Such forward looking statements involve known and unknown risk, uncertainties and other factors which may cause the actual results or performance of Johnson Electric to be materially different from any future results or performance expressed or implied by such forward looking statements. Such forward looking statements are based on numerous assumptions regarding Johnson Electric’s present and future business strategies and the political and economic environment in which Johnson Electric will operate in the future.
Note to Editors and Securities Analysts: The full text of the Annual Results announcement, includingfinancial statements, is available through the Investors section of company’s website at www.johnsonelectric.com Hashtag: #JohnsonElectric
The issuer is solely responsible for the content of this announcement.
About Johnson Electric Group
At Johnson Electric, our vision is to be the world’s definitive provider of innovation and reliable motion systems.
We are a global leader in electric motors, actuators, motion subsystems and related electro-mechanical components, serving a broad range of industries including Automotive, Liquid Cooling, Robotic Joints, Smart Metering, Business Equipment, Ventilation, Home Automation, Large Appliances, Power Tools, Medical Devices and Lawn & Garden Equipment. The Group is headquartered in Hong Kong and employes over 30,000 individuals in more than 20 countries worldwide. We are listed on The Stock Exchange of Hong Kong Limited ( Stock no. 179). For further information, please visit: www.johnsonelectric.com.
Roundcube Webmail administrators are being pressed to install emergency updates after maintainers fixed a set of security flaws that could expose email systems to database manipulation, script injection, server-side request forgery and other attacks. Versions 1.6.16 and 1.7.1, released on 24 May 2026, address vulnerabilities affecting the 1.6 long-term support line and the 1.7 branch. The most closely watched issue is a pre-authentication SQL injection flaw in [...]
Prudent Risk Management Yields Solid Outcomes metrics, Core Pawn Business Demonstrates Resilient Growth with Proposed Final Dividend of HK$1.15 cents per share
Results Highlights:
Profit for the year attributable to shareholders increased by approximately 47.8% YoY to approximately HK$82.6 million
Net profit margin increased by approximately 16.2 p.p. YoY to approximately 50.2%
Impairment losses recognized on loan receivables decreased by approximately 72.6% YoY to HK$12.7 million
Revenue from pawn loan business increased by approximately 12.9% YoY to approximately HK$98.6 million
Proposed final dividend of HK$1.15 cents per share
HONG KONG SAR – Media OutReach – 27 May 2026 – The board of directors of Oi Wah Pawnshop Credit Holdings Limited (HKEx stock code: 1319.HK, the “Group” or “Oi Wah”) announced its annual results and its financial position. For the year ended 28 February 2026 (“FY2026“), the Group recorded revenue of approximately HK$164.4 million. Profit attributable to shareholders of the Company reached approximately HK$82.6 million, representing an increase of 47.8% compared to the year ended 28 February 2025 (“FY2025“). During the year, net interest margin expanded to approximately 17.2%.
As of 28 February 2026, the cash and cash equivalents (net of bank overdraft) amounted to approximately HK$376.9 million, representing a substantial increase of approximately 74.8% YoY. The net assets increased to approximately HK$1,155.7 million. Concurrently, the gearing ratio dropped to 4.1%. During the year, the earnings per share increased by approximately 48.3% YoY to HK 4.3 cents. The Board of Directors recommends a final dividend of HK 1.15 cents per share.
BUSINESS REVIEW
Mortgage loan business
In FY2026, the economy entered a phase of gradual recovery, leading to a steady resurgence in financing demand. The revenue from the mortgage loan business was approximately HK$65.8 million and accounted for approximately 40.0% of the Group’s total revenue during the year. The gross mortgage loan receivables were approximately HK$612.5 million as at 28 February 2026. During the year, net interest margin of the mortgage loan business was approximately 10.1%.
In FY2026, the Group maintained a disciplined and risk-sensitive approach in its lending activities. While we observed an encouraging stabilization in the residential property market, the Group exercised intensified vigilance toward the commercial and industrial sectors due to persistent supply overhangs and valuation pressures. Our underwriting strategy remained focused on building a resilient loan portfolio by prioritizing high-quality collaterals and prudent loan-to-value ratios. During the year, the average loan-to-value ratio for first mortgage was approximately 56.27%, while overall average loan-to-value ratio for subordinate mortgage was approximately 40.82% of which, average loan-to-value ratio of subordinate mortgage that the Group participated in was approximately 3.73%.
Reflecting our robust credit risk management, the charge for impairment losses recognized on loan receivables decreased from approximately HK$46.3 million to approximately HK$12.7 million, representing a decrease of approximately 72.6% or HK$33.6 million.
Pawn Loan Business
The revenue from the pawn loan business increased by approximately 12.9% to approximately HK$98.6 million in FY2026. The business’s profitability was further bolstered by a significant 73.0% increase in the gain on disposal of repossessed assets, which reached approximately HK$19.2 million as compared to approximately HK$11.1 million in FY2025. This performance was mainly attributed to the unprecedented strength of gold prices and a highly active secondary market for luxuries, particularly high-end timepieces. These factors have further solidified the pawn loan business as a resilient and strategic hedge against broader economic volatility.
During the year, the Group continued to channel resources to advertising and promotion to enhance the Group’s brand exposure. Such effort has generated demand for one-to-one pawn loan appointment services for pawn loans exceeding HK$0.1 million.
PROSPECTS
Looking ahead, the Group maintains a stance of cautious optimism regarding the global economic recovery. While macroeconomic and geopolitical uncertainties may persist, we remain dedicated to a proactive yet prudent strategy to ensure sustainable long-term growth and maximize returns for our shareholders.
Within the mortgage loan market, our strategy will be characterized by a calibrated and divergent approach. We continue to hold an optimistic outlook on the residential property segment, where we intend to capitalize on the stabilizing interest rate environment by identifying high-quality mortgage opportunities. Conversely, we maintain cautious and vigilant towards the commercial and industrial sectors. Given the structural challenges of inventory overhang and the increasing prevalence of distressed assets, the Group will exercise intensified oversight in its credit underwriting and collateral appraisal to mitigate valuation risks.
Regarding our core operations, we anticipate our pawn loan business to remain resilient, supported by a firm gold price trajectory and sustained demand for liquidity management. To further enhance operational efficiency, the Group is actively optimizing its pawn shop network. We are strategically identifying more cost-effective locations within our established service areas, aiming to relocate our pawn outlets to premises with more competitive lease terms to reduce operating overheads while maintaining our leading market presence.
Simultaneously, our strategic partnership with PACM Group remains a key driver for geographic diversification. By proactively exploring institutional credit opportunities in developed markets while maintaining rigorous investment oversight, the Group is well-positioned to navigate evolving industry dynamics and deliver stable value to all stakeholders.
Mr. Edward Chan, Chairman and CEO of the Company, said, “Global geopolitical and macroeconomic uncertainties intertwine, placing pressure on the global economic recovery and posing ongoing challenges to the local property market. In the face of a complex external environment, Oi Wah has consistently adhered to a proactive yet prudent management strategy. Our core pawn loan business has fully demonstrated its role as a strategic tool to hedge against macroeconomic fluctuations, showcasing the Group’s strong resilience amidst market challenges.
Looking forward, we will adopt a carefully calibrated differentiation strategy and continue to drive regional diversification. Under strict investment monitoring, we will actively explore business opportunities in developed markets to further expand our revenue streams and customer base, striving to deliver long-term, stable, and sustainable returns for our shareholders.”
Hashtag: #OiWah
The issuer is solely responsible for the content of this announcement.
About Oi Wah Pawnshop Credit Holdings Limited
Oi Wah is a financing service provider in Hong Kong, mainly providing short-term secured financing, including pawn loans and mortgage loans. The Group established its first pawnshop in 1975 and currently owns 10 pawnshops and one premium service center in various locations in Hong Kong. Oi Wah diversified into mortgage loan business in 2009. The Group is the first local pawn shop which successfully listed on the Main Board of The Stock Exchange of Hong Kong Limited on 12 March 2013.
Another significant step towards the success of ICVAX®
HONG KONG SAR – Media OutReach Newswire – 27 May 2026 – Immuno Cure Group (“Immuno Cure“), headquartered at Hong Kong Science Park, is pleased to announce the inauguration of the research facility for its HIV therapeutic DNA vaccine (“ICVAX®“) at the Center of International Innovation for Technology and Science (“CIITS”) located in Hetao, Shenzhen. The facility aims for the development and application of key technologies for the clinical research and commercialization of Immuno Cure’s ICVAX®. ICVAX® is developed by Immuno Cure with the aim of achieving antiretroviral therapy (“ART“)-free functional cure for HIV infection. This project is carried out in collaboration with Prof. Zhiwei CHEN, the Founding Director of the AIDS Institute of Li Ka Shing Faculty of Medicine, the University of Hong Kong (“HKU AIDS Institute“), and Prof. Hongzhou LU, President of the Third People’s Hospital of Shenzhen, in the capacity as advisors.
From left to right: Dr.Tengfei CAO, Deputy Director of CIITS; Mr. Tom LAU, Corporate Finance Director and Co-Founder of Immuno Cure; Dr. Renchen LIU, Executive Deputy Dean of Research Institute of Tsinghua University in Shenzhen and Director of CIITS; Dr. Xia JIN, CEO and Co-Founder of Immuno Cure; Prof. Zhiwei CHEN, Principal Scientific Advisor and Co-founder of Immuno Cure; Dr. Percy CHENG, Chairman and Co-Founder of Immuno Cure
CIITS is a national-level achievement transformation platform co-built by Guangdong Province, Shenzhen Municipality, and Tsinghua University, and is located at the Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone (“Hetao Co-operation Zone“). It is committed to building a world’s leading major technological innovation and industrialization platform with a global perspective. It focuses on key tracks including biomedicine, high-performance materials, and artificial intelligence (AI). It aims to aggregate global innovation resources, connect with leading enterprises, and conduct organized scientific research and achievement transformation to address national major strategic needs.
Since AIDS was first identified in 1981, 40.8 million people have died from HIV infection, with over 44.1 million people living with HIV globally. While antiretroviral therapy can effectively control HIV replication, it cannot cure the disease, highlighting the critical need for immunotherapies. Designed to enhance the host’s immune response, immunotherapies aim to achieve sustained viral control without lifelong ART, ultimately leading to complete viral suppression and functional cure. Immuno Cure’s proprietary innovative HIV therapeutic DNA vaccine, ICVAX®, induces broad-spectrum, polyfunctional virus-specific T cells to achieve the ultimate goal of ART-free functional cure of HIV infection.
Immuno Cure completed the first-in-human Phase I clinical trial of ICVAX® in November 2024, demonstrating excellent safety and promising immunogenicity. Two multi-center Phase II clinical trials—randomized, double-blind, and placebo-controlled—are scheduled to launch in Q2-2026 to evaluate the vaccine’s mechanism of action and efficacy. The trials will be conducted at Prince of Wales Hospital in Hong Kong, as well as eight top-tier hospitals in China, including the Shenzhen Third People’s Hospital, Beijing Ditan Hospital Affiliated to Capital Medical University, Beijing Youan Hospital affiliated to Capital Medical University, the Eighth People’s Hospital of Guangzhou, the Second People’s Hospital of Tianjin, the Sixth People’s Hospital of Zhengzhou, Chengdu Public Health Clinical Medical Center, and Chongqing Public Health Medical Center.
Notably, standardized testing systems for evaluating immunological and virological indicators are crucial for HIV vaccine clinical trials. However, the lack of domestic standard operating procedures (SOPs) for infectious samples in clinical trials hinders the clinical development and regulatory approval of novel infectious disease therapies like ICVAX®. The mission of this research facility at CIITS is to establish an internationally aligned standardized clinical testing system for T-cell immunogenicity and viral reservoirs, as well as identify core biomarkers associated with vaccine efficacy — filling a domestic technical gap. Immuno Cure will offer the ICVAX® Phase II clinical trial to facilitate the development of this standardized precision testing method for clinical sample analysis.
Dr. Xia JIN, CEO of Immuno Cure, stated, “I am delighted to be appointed to lead this key project of CIITS. I would also like to thank CIITS for the fully fitted modern laboratory space and the RMB10.0m funding support for this 2-year initial phase. My whole scientific team is committed to contributing diligently to the success of this project. I have no doubt that the development of a standardised testing regime would not only enhance the quality of our clinical trials for ICVAX® but would also eventually be adopted as industry and national standards for the clinical translation of medicine for HIV/AIDS and other infectious diseases.
Renchen LIU, Executive Deputy Dean of Research Institute of Tsinghua University in Shenzhen and Director of CIITS, stated, “Warmest congratulations on the inauguration of the research facility for ICVAX® at the CIITS. In the future, CIITS will continue to leverage its platform resources to implement full-chain incubation services. Project managers will provide service support throughout the entire project period, ensuring the smooth progress of the project through resource integration, talent recruitment and development, clinical collaboration, and achievement transformation. These efforts will safeguard the steady progress of the project.”
As the project advances, Immuno Cure’s ICVAX® is positioned to become the world’s first therapeutic DNA vaccine to deliver an ART-free functional cure for HIV infection, bringing new hope to people currently living with HIV. In parallel, the standardized testing platform and collaborative innovation model developed through this effort will provide a scalable, replicable blueprint for R&D of novel therapies targeting other major infectious diseases. Together, these outcomes will strengthen the global competitiveness of biomedicine development in GBA and contribute to the development of national biosecurity capabilities and a more resilient public health system.
The issuer is solely responsible for the content of this announcement.
About the Center of International Innovation for Technology and Science (“CIITS”)
Center of International Innovation for Technology and Science (CIITS), as the international headquarter of the Greater Bay Area National Center of Technology Innovation (GBA NCTI), is operated by Research Institute of Tsinghua University in Shenzhen (RITS). CIITS actively promotes the commercialization of technology and scientific advances with overseas and domestic innovation institutions and teams, as well as industry partners, focusing on areas such as biomedicine, advanced materials and artificial intelligence.
To learn more about CIITS, please follow the WeChat official account: gh_425f503135d5
About Immuno Cure
Immuno Cure is a clinical-stage biotechnology group headquartered at Hong Kong Science Park. Immuno Cure is committed to the R&D of innovative DNA vaccines and antibody immunotherapies for infectious diseases, inflammations, and cancers. Immuno Cure possesses two technologies: the “PD-1 Enhanced DNA Vaccine Platform” and the “Anti-Δ42PD1 Antibody”.
Binance has opened a supervised route back into the Philippines through a partnership with BlockShoals Technologies Inc., placing the world’s largest crypto exchange inside the Philippine Securities and Exchange Commission’s Strategic Sandbox after two years of regulatory tension over unlicensed offshore platforms.
The arrangement makes BlockShoals the approved local intermediary under the SEC’s StratBox framework, while Binance supplies technology, security systems, operational support and compliance expertise developed across regulated markets. The sandbox phase is expected to begin in the second half of 2026 and run for at least two years, giving regulators direct oversight of product testing before any wider rollout to users.
The move marks a notable shift in Binance’s strategy in the Philippines. Rather than seeking to restore access through an offshore model, the exchange is now pursuing market participation through a domestic company operating under SEC supervision. BlockShoals, a Philippine-incorporated fintech firm, secured approval under the crypto asset intermediary framework after a multi-year process involving regulatory conditions, compliance checks and investor-protection requirements.
Binance’s online presence in the Philippines was blocked in 2024 after the SEC said the platform had offered investment and trading services without the necessary licence. The regulator had warned the public about the exchange in November 2023, then moved to restrict website access through telecommunications authorities the following year. The action became one of the clearest signals that Manila intended to bring offshore digital-asset platforms under local rules.
That enforcement drive has since widened. The SEC’s crypto-asset service provider rules, issued in 2025, require firms serving Philippine users to register, maintain sufficient capital, observe marketing standards, and meet operational and reporting obligations. The framework is intended to protect retail investors while allowing controlled innovation in a market where crypto use remains high by regional and global standards.
The Philippines ranked ninth in the 2025 global crypto adoption index, reflecting strong activity across retail centralised services and digital-asset platforms. Usage has been driven by a young, mobile-first population, remittance demand, online work, gaming-linked crypto activity and a broad appetite for alternative financial products. That adoption has also heightened regulatory concern over fraud, weak disclosures, market volatility and the risks of foreign platforms serving users without domestic accountability.
Seker, Binance’s head of Asia-Pacific, described the Philippines as one of Southeast Asia’s most dynamic digital economies, saying frameworks such as StratBox create a channel for regulators and industry participants to work together while maintaining user protection and market integrity. The company has presented the BlockShoals partnership as part of a compliance-first approach rather than a conventional market relaunch.
BlockShoals has framed its role around local accountability. A company representative said the partnership was an opportunity to show that global digital-asset platforms and domestic regulatory frameworks could operate constructively together, adding that the firm would work under direct SEC supervision while building a secure platform for users.
The sandbox structure gives the SEC room to monitor how products are configured, how customer onboarding is handled, how risks are disclosed, and how safeguards such as know-your-customer checks, anti-money-laundering controls and transaction monitoring are applied. It also gives Binance a pathway to rebuild trust after a period in which its Philippine operations were defined by access restrictions and licensing concerns.
The Philippine approach mirrors a broader shift across Asia, where regulators are moving away from informal tolerance of offshore crypto activity and towards domestic licensing regimes. Singapore, Hong Kong, Thailand, Indonesia and Japan have tightened rules for exchanges, stablecoin activity, custody, marketing and investor suitability. The result is a more fragmented operating environment for global platforms, with access increasingly dependent on local registration, capital commitments and regulator-facing governance.
For Binance, the Philippine partnership carries strategic value beyond one market. The exchange has spent the past several years seeking to repair relations with regulators after facing scrutiny in multiple jurisdictions. A successful sandbox test in Manila would support its argument that global crypto platforms can adapt to local rules through partnerships, product controls and supervised deployment.
https://www.xtransfer.com
https://www.linkedin.com/company/xtransfer.cn
https://www.facebook.com/AmarisBClinic/
https://www.instagram.com/amarisbclinic/
https://www.tiktok.com/@amarisbclinic
https://www.youtube.com/amarisbclinic
